[1]
Tabasheri, M. et al. 2025. Engineered mesenchymal stem cells: A novel approach for Th2-targeted modulation in allergic asthma. Allergologia et Immunopathologia. 53, 6 (Nov. 2025), 162–174. DOI:https://doi.org/10.15586/aei.v53i6.1507 .